Cargando…

Celecoxib Inhibits the Lytic Activation of Kaposi’s Sarcoma-Associated Herpesvirus through Down-Regulation of RTA Expression by Inhibiting the Activation of p38 MAPK

Kaposi’s sarcoma associated herpesvirus (KSHV) is the etiologic agent of Kaposi’s sarcoma (KS), primary effusion lymphoma (PEL), and multicentric Castleman’s disease (MCD). KSHV’s lytic replication cycle is critical for the pathogenesis of KSHV-associated diseases. Despite recent progress in the dev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jungang, Jiang, Liangyu, Lan, Ke, Chen, Xulin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452905/ https://www.ncbi.nlm.nih.gov/pubmed/25951487 http://dx.doi.org/10.3390/v7052268

Ejemplares similares

Gallic acid inhibits Kaposi's Sarcoma‐associated herpesvirus lytic reactivation by suppressing RTA transcriptional activities
por: Long, Wen‐Ying, et al.
Publicado: (2020)

Kaposi's Sarcoma-Associated Herpesvirus ORF6 Gene Is Essential in Viral Lytic Replication
por: Peng, Can, et al.
Publicado: (2014)

Epstein–Barr Virus (EBV) Rta-Mediated EBV and Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivations in 293 Cells
por: Chen, Yen-Ju, et al.
Publicado: (2011)

NCOA2 promotes lytic reactivation of Kaposi’s sarcoma-associated herpesvirus by enhancing the expression of the master switch protein RTA
por: Wei, Xiaoqin, et al.
Publicado: (2019)

Reactivation and Lytic Replication of Kaposi’s Sarcoma-Associated Herpesvirus: An Update
por: Aneja, Kawalpreet K., et al.
Publicado: (2017)

Nucleolar stress enhances lytic reactivation of the Kaposi’s sarcoma-associated herpesvirus
por: Gelgor, Anastasia, et al.
Publicado: (2018)

Cellular MicroRNAs 498 and 320d Regulate Herpes Simplex Virus 1 Induction of Kaposi’s Sarcoma-Associated Herpesvirus Lytic Replication by Targeting RTA
por: Yan, Qin, et al.
Publicado: (2013)

Kaposi’s Sarcoma-Associated Herpesvirus Lytic Replication Is Independent of Anaphase-Promoting Complex Activity
por: Elbasani, Endrit, et al.
Publicado: (2020)

Activation of IL1 signaling molecules by Kaposi’s sarcoma-associated herpesvirus
por: Chen, Jungang, et al.
Publicado: (2022)

Efficient lytic induction of kaposi's sarcoma-associated herpesvirus (KSHV) by the anthracyclines
por: Kang, Hyunju, et al.
Publicado: (2014)

Identification of new antiviral agents against Kaposi’s sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation
por: Chen, Jungang, et al.
Publicado: (2019)

Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus
por: Chang, Pey-Jium, et al.
Publicado: (2017)

Ser-634 and Ser-636 of Kaposi’s Sarcoma-Associated Herpesvirus RTA are Involved in Transactivation and are Potential Cdk9 Phosphorylation Sites
por: Tsai, Wan-Hua, et al.
Publicado: (2012)

Kaposi's Sarcoma-Associated Herpesvirus K-Rta Exhibits SUMO-Targeting Ubiquitin Ligase (STUbL) Like Activity and Is Essential for Viral Reactivation
por: Izumiya, Yoshihiro, et al.
Publicado: (2013)

Activation of RSK and ERK MAPK kinases by ORF45 of Kaposi's sarcoma-associated herpesvirus
por: Zhu, F, et al.
Publicado: (2009)

Suppressing Kaposi’s Sarcoma-Associated Herpesvirus Lytic Gene Expression and Replication by RNase P Ribozyme
por: Liu, Yujun, et al.
Publicado: (2023)

Fine-Tuning of the Kaposi’s Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway
por: Li, Shasha, et al.
Publicado: (2016)

Importance of Promyelocytic Leukema Protein (PML) for Kaposi’s Sarcoma-Associated Herpesvirus Lytic Replication
por: Hossain, Md. Golzar, et al.
Publicado: (2018)

Dimethyl Sulfoxide Enhances Kaposi’s Sarcoma-Associated Herpesvirus Production During Lytic Replication
por: Kang, Su-Kyung, et al.
Publicado: (2021)

Lytic Reactivation of the Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) Is Accompanied by Major Nucleolar Alterations
por: Atari, Nofar, et al.
Publicado: (2022)

ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle
por: Wood, Jennifer J., et al.
Publicado: (2016)

Kaposi sarcoma herpesvirus pathogenesis
por: Mariggiò, Giuseppe, et al.
Publicado: (2017)

Thymus capitatus flavonoids inhibit infection of Kaposi's sarcoma‐associated herpesvirus
por: Mekni‐Toujani, Marwa, et al.
Publicado: (2022)

Role of Histamine and Related Signaling in Kaposi’s Sarcoma-Associated Herpesvirus Pathogenesis and Oncogenesis
por: Chen, Jungang, et al.
Publicado: (2023)

Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription
por: Ali, Ahmed, et al.
Publicado: (2022)

Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV–MCD) and the KSHV Inflammatory Cytokine Syndrome
por: Polizzotto, Mark N., et al.
Publicado: (2012)

Widespread Traces of Lytic Kaposi Sarcoma-Associated Herpesvirus in Primary Effusion Lymphoma at Single-Cell Resolution
por: Rondeau, Nicole C., et al.
Publicado: (2020)

NDRG1 facilitates lytic replication of Kaposi’s sarcoma-associated herpesvirus by maintaining the stability of the KSHV helicase
por: Dong, Lianghui, et al.
Publicado: (2021)

Kaposi’s sarcoma-associated herpesvirus induces specialised ribosomes to efficiently translate viral lytic mRNAs
por: Murphy, James C., et al.
Publicado: (2023)

Mutual Inhibition between Kaposi's Sarcoma-Associated Herpesvirus and Epstein-Barr Virus Lytic Replication Initiators in Dually-Infected Primary Effusion Lymphoma
por: Jiang, Yanjun, et al.
Publicado: (2008)

Lysine residues of interferon regulatory factor 7 affect the replication and transcription activator-mediated lytic replication of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8
por: Zhang, Tianzheng, et al.
Publicado: (2011)

Nelfinavir Inhibition of Kaposi’s sarcoma-associated herpesvirus protein expression and capsid assembly
por: Li, Maggie, et al.
Publicado: (2023)

Kaposi’s Sarcoma Herpesvirus Genome Persistence
por: Juillard, Franceline, et al.
Publicado: (2016)

Kaposi's sarcoma-associated herpesvirus at 27
por: Gaglia, Marta Maria
Publicado: (2021)

Human herpesvirus 8 in Kaposi's sarcoma and Kaposi's sarcoma-mimicking vascular tumors.
por: Kang, G. H., et al.
Publicado: (1998)

Corrigendum: Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV–MCD) and the KSHV inflammatory cytokine syndrome
por: Polizzotto, Mark N., et al.
Publicado: (2017)

Characterization of lytic human herpesvirus-8 gene expression in Kaposi sarcoma tumor tissue and its clinical correlates
por: Phipps, Warren, et al.
Publicado: (2010)

Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi’s Sarcoma-Associated Herpesvirus Latent and Lytic Replications
por: Gruffaz, Marion, et al.
Publicado: (2018)

CRISPR Interference Efficiently Silences Latent and Lytic Viral Genes in Kaposi’s Sarcoma-Associated Herpesvirus-Infected Cells
por: Brackett, Kevin, et al.
Publicado: (2021)

Activation of PI3K/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi's Sarcoma-associated herpesvirus by herpes simplex virus type 1
por: Qin, Di, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9k5mkh3t8g0sfi0emci3libaau